Cargando…
The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy
BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the world, with 694,000 deaths each year. Despite improvements in treatment strategies in recent years, the overall survival rate of CRC is still very low and the survival rate is highly dependent on the stage at the time of diag...
Autores principales: | Wang, Jun, Liang, Wenjia, Wang, Xiangwen, Min, Guangtao, Chen, Wei, Wang, Hongpeng, Yao, Nan, Wang, Jiancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587652/ https://www.ncbi.nlm.nih.gov/pubmed/31192959 http://dx.doi.org/10.1097/MD.0000000000016034 |
Ejemplares similares
-
Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons
por: Hua, Jinyong, et al.
Publicado: (2019) -
Hormonal biomarkers for the noninvasive diagnosis of endometriosis: A protocol for a network meta-analysis of diagnostic test accuracy
por: Shen, Minghui, et al.
Publicado: (2018) -
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
por: Wang, Xiangwen, et al.
Publicado: (2023) -
Diagnostic test accuracy of novel biomarkers for lupus nephritis—An overview of systematic reviews
por: Guimarães, Juliana de Andrade Rebouças, et al.
Publicado: (2022) -
An overview of systematic reviews of diagnostic tests accuracy
por: Bae, Jong-Myon
Publicado: (2014)